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Résumé en
anglais
Because of the complex biological networks, many pathologic disorders fail to be
treated with a molecule directed towards a single target. Thus, combination therapies
are often necessary, but they have many drawbacks. An alternative consists in building
molecules intended to interact with multiple targets, called designed multiple ligands.
We followed such a strategy in order to treat metabolic syndrome, by setting up
molecules directed towards both type 1 angiotensin II (AT1) receptor and peroxisome
proliferator-activated receptor-γ (PPAR-γ). For this purpose, many molecules were
prepared by merging both pharmacophores following three different strategies. Their
ability to activate PPAR-γ and to block AT1 receptors were evaluated in vitro. This
strategy led to the preparation of many new PPAR-γ activating and AT1 blocking
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